Yonsei University: Clinical Trials

1,458 trials sponsored by Yonsei University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

773 completed, 397 unknown, 120 recruiting, 74 not yet recruiting. 646 Not applicable, 199 Phase 4, 172 Phase 2, 43 Phase 3, 42 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable646Completed 390, Unknown 140, Recruiting 45, Not yet recruiting 35, Terminated 17, Withdrawn 13, Active not recruiting 5, Enrolling by invitation 1
Phase 4199Completed 116, Unknown 47, Recruiting 15, Not yet recruiting 8, Terminated 6, Active not recruiting 4, Withdrawn 3
Phase 2172Completed 65, Unknown 57, Recruiting 19, Not yet recruiting 14, Active not recruiting 10, Withdrawn 4, Terminated 2, Enrolling by invitation 1
Phase 343Completed 23, Unknown 14, Not yet recruiting 2, Terminated 2, Recruiting 1, Withdrawn 1
Phase 142Completed 21, Recruiting 6, Unknown 6, Not yet recruiting 5, Withdrawn 3, Active not recruiting 1

Follow Yonsei University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dapagliflozin in Patients With Non-Obstructive Hypertrophic Cardiomyopathy: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Dapagliflozin 10mg, Dapagliflozin Placebo - Nonobstructive Hypertrophic Cardiomyopathy
Phase 4Not yet recruitingYonsei University4402027-01-022026-10-27
Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease
Sitagliptin, Sitagliptin placebo - Parkinson Disease
Phase 2Not yet recruitingYonsei University1602026-12-152026-09-10
Effect of Double-Tap Optimization on Valve Expansion and Hemodynamics in Balloon-expandable Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial (DO-OPT TAVI Trial)
Double-Tap Balloon Post-dilatation, Conventional Single-Inflation TAVI - Severe Aortic Stenosis
Not applicableNot yet recruitingYonsei University2502026-12-012026-11-03
Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis
Crezet 2.5/10mg, Litorvazet 5/10mg, Baroezet 1/10mg - Atherosclerosis Cardiovascular Disease
Phase 4Not yet recruitingYonsei University3002026-11-102026-10-16
Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA
Angionix Balloon - Coronary Artery Disease
Not yet recruitingYonsei University6002026-11-092026-10-09
Lenvatinib in Patients With Advanced Parathyroid Carcinoma
Lenvatinib - Parathyroid Carcinoma
Phase 2Not yet recruitingYonsei University182026-11-012026-09-28
Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer
Lurbinectedin, Paclitaxel - Carcinoma, Small Cell Lung
Phase 2Not yet recruitingYonsei University692026-11-012026-09-04
Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma
Pembrolizumab and Irinotecan - Unresectable or Metastatic Melanoma
Phase 1 / Phase 2Not yet recruitingYonsei University462026-11-012026-09-14
Electrophysiological Dose-Response to Anterior Thalamic Deep Brain Stimulation in Drug-Resistant Focal Epilepsy
Anterior thalamic deep brain stimulation with a standardized amplitude schedule and acute stimulation challenges - Drug Resistant Epilepsy, Focal Epilepsy
Not applicableNot yet recruitingYonsei University102026-11-012026-11-03
SVF Cellular Composition, Secretome, and Responses in Knee Osteoarthritis
Autologous adipose-derived stromal vascular fraction intra-articular injection - Osteoarthritis, Knee
RecruitingYonsei University202026-11-012026-10-27
Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction
BioBrace® Reinforced BioInductive Implant - Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Not applicableNot yet recruitingYonsei University302026-11-012026-10-30
Intertransverse Process Block Versus Transversus Abdominis Plane Block After Robot, Laparoscopic Hepatectomy
Ultrasound-Guided Bilateral Intertransverse Process Block, Ultrasound-Guided Bilateral Oblique Subcostal TAP Block Plus Rectus Sheath Block - Postoperative Pain
Not applicableNot yet recruitingYonsei University642026-10-192026-11-16
Educational Methods for Learning Thyroid Ultrasound Interpretation in Medical Students
Traditional 1:1 apprenticeship training, Passive image self-learning, AI-CAD-assisted self-learning - Thyroid Nodule, Education
Not applicableActive not recruitingYonsei University402026-10-092026-11-20
An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal Cancer Chemotherapy
Sedentary behavior reduction intervention for patients with colorectal cancer undergoing chemotherapy - Colorectal Neoplasms, Sedentary Behavior
Not applicableNot yet recruitingYonsei University402026-10-012026-09-29
A Phase 2 Multicenter Single-Arm Clinical Trial of Zanzalintinib and Pembrolizumab in Subjects With Resectable Clear Cell Renal Cell Carcinoma
Zanzalintinib and Pembrolizumab - Patients With Locally Advanced or Metastatic But Resectable Clear Cell Renal Cell Carcinoma
Phase 2Not yet recruitingYonsei University482026-10-012026-07-09
Procedural Endpoint in Left Bundle Branch Area Pacing: Conduction System Capture Versus LV Septal Capture
LBBAP with mandatory left ventricular conduction system capture (LBBP or LFP), LBBAP with left ventricular septal capture as the accepted procedural endpoint (LVSP) - Bradycardia, Atrioventricular Block
Not applicableNot yet recruitingYonsei University3002026-10-012026-09-04
Erector Spinae Oxygen Saturation and AKI After OPCAB
Near-infrared spectroscopy monitoring of erector spinae muscle and renal regional oxygen saturation - Acute Kidney Injury, Coronary Artery Disease
Not yet recruitingYonsei University1382026-10-012026-08-12
Coronary Access After Evolut FX Plus TAVI: Impact of Commissural Alignment and the Large-Cell Frame Design: ACCESS-FX+ Registry
Severe Aortic Stenosis
Not yet recruitingYonsei University1222026-09-292026-09-10
JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Failure
JIN-A02 in Combination with Amivantamab - Carcinoma, Non-Small-Cell Lung
Phase 1Not yet recruitingYonsei University362026-09-282026-09-02
Associations of Postoperative Hemoglobin With AKI-AKD Trajectories
Patients Undergoing Valvular Heart Surgery
Active not recruitingYonsei University42302026-09-182026-10-30

Showing 20 of 1458. Sign in to see all of them.

Conditions studied

Stomach Neoplasms (66)  ·  Coronary Artery Disease (61)  ·  Atrial Fibrillation (49)  ·  Breast Neoplasms (27)  ·  Stroke (23)  ·  Carcinoma, Non-Small-Cell Lung (22)  ·  Colorectal Neoplasms (19)  ·  Acute Kidney Injury (18)  ·  Pancreatic Neoplasms (18)  ·  Diabetes Mellitus, Type 2 (17)  ·  Lung Neoplasms (17)  ·  Ovarian Neoplasms (16)  ·  Prostatic Neoplasms (16)  ·  Heart Failure (15)  ·  Pain, Postoperative (15)

Interventions

Saline Solution (47)  ·  Dexmedetomidine (33)  ·  Propofol (29)  ·  Sodium Chloride (21)  ·  Control Groups (18)  ·  Cisplatin (15)  ·  Remifentanil (15)  ·  Atorvastatin (14)  ·  Docetaxel (13)  ·  pembrolizumab (13)  ·  Paclitaxel (12)  ·  Ropivacaine (11)  ·  Desflurane (10)  ·  Dexamethasone (10)  ·  Ezetimibe (10)

Countries

South Korea (1329)  ·  Japan (3)  ·  Singapore (3)  ·  Taiwan (3)  ·  Hong Kong (2)  ·  Australia (1)  ·  China (1)  ·  Indonesia (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Yongcheol Kim, MD, PhD (9)  ·  Deog Young Kim (8)  ·  Na Young Kim, MD, PhD (8)  ·  Hye Ryun Kim (7)  ·  Jong Ho Lee, PhD (7)  ·  Gong Je Seong, MD, PhD (6)  ·  Hui-Nam Pak (6)  ·  Joo-Hang Kim, MD (6)  ·  Byeong-Keuk Kim (5)  ·  Hyuk-Jae Chang, MD, PhD (5)  ·  Jong Ho Lee, Ph.D (5)  ·  Jong Ho Lee, Ph.D. (5)  ·  Bon-Nyeo Koo (4)  ·  Sang Hoon Ahn, MD, PhD (4)

Results publications

PMID 41044734, PMID 20039582, PMID 20590073, PMID 21740078, PMID 24556672, PMID 24812254, PMID 26971404, PMID 30475845, PMID 31141973, PMID 32588238, PMID 41548032, PMID 41697655, PMID 10093981, PMID 10155411, PMID 10434218, PMID 10463984, PMID 11028480, PMID 11096167, PMID 11194105, PMID 11359154, PMID 11401954, PMID 11529208, PMID 11585919, PMID 11822946, PMID 11881867, PMID 12008173, PMID 12378346, PMID 12383306, PMID 12560776, PMID 12616125, PMID 12733140, PMID 1281903, PMID 12821592, PMID 12833452, PMID 14066104, PMID 14524486, PMID 1455316, PMID 14693597, PMID 14693633, PMID 14739848, PMID 14755223, PMID 15082593, PMID 15173543, PMID 15374844, PMID 15385355, PMID 15390043, PMID 15459926, PMID 15507257, PMID 15579771, PMID 15689746

NIH funding

2019 (1)